feiba 500 u
1 glass vial powder + 1 vial with 20ml solvent + 1 baxject ii hi-flow + 1 kit -
feiba tim 4 immuno 1000
adcock ingram critical care (pty) ltd - factor viii inhibitor - injection - each 1 ml solution contains: factor viii inhibitor bypassing activity 50 u
feiba tim 4 imuno 500
adcock ingram critical care (pty) ltd - factor viii inhibitor - injection - each 1 ml solution contains: factor viii inhibitor bypassing activity 50 iu
feiba 50u powder&solvent powder and solvent for solution for infusion
takeda manufacturing ag, austria - anti inhibitor coagulant complex - powder and solvent for solution for infusion - 50 iu/ml
feiba 25 u/ml powder & solvent powder and solvent for solution for infusion
takeda manufacturing ag, austria - omfiloctocog alfa - powder and solvent for solution for infusion - 25 iu/ml
feiba 1000 u/20 ml (50 u/ml) powder for solution for infusion (iv)
n/a; importer: takeda healthcare philippines inc.; distributor: takeda healthcare philippines inc. - factor viii inhibitor bypassing activity - powder for solution for infusion (iv) - 1000 u/20 ml (50 u/ml)
feiba 2500 u/50 ml (50 u/ml) powder for solution for infusion (iv)
n/a; importer: takeda healthcare philippines inc.; distributor: takeda healthcare philippines inc. - powder for solution for infusion (iv) - powder for solution for infusion (iv) - 2500 u/50 ml (50 u/ml)
medicine administration kit, percutaneous, medicated, single-use
takeda pharmaceuticals australia pty ltd - 45156 - medicine administration kit, percutaneous, medicated, single-use - the procedure pack is intended for preparing the injection solution of feiba nf for administration. the pack consists of the a drug powder vial, a diluent vial and a baxject ii reconstitution device. baxject ii is a needleless transfer device which is intended for transferring and mixing the diluent and the drug powder contained in the two vials into a syringe for administration. this procedure pack is for single-use only.
hemlibra
roche products (nz) ltd - emicizumab 150 mg/ml - solution for injection - 150 mg/ml - active: emicizumab 150 mg/ml excipient: arginine aspartic acid histidine poloxamer 188 water for injection - hemlibra is indicated for routine prophylaxis to prevent bleeding or reduce the frequency of bleeding episodes in adult and paediatric patients with haemophilia a (congenital factor viii deficiency) with or without factor viii inhibitors.
hemlibra
roche products (nz) ltd - emicizumab 150 mg/ml - solution for injection - 150 mg/ml - active: emicizumab 150 mg/ml excipient: arginine aspartic acid histidine poloxamer 188 water for injection - hemlibra is indicated for routine prophylaxis to prevent bleeding or reduce the frequency of bleeding episodes in adult and paediatric patients with haemophilia a (congenital factor viii deficiency) with or without factor viii inhibitors.